论文部分内容阅读
目的探讨虾青素胶囊对高脂血症人群辅助降血脂作用。方法将110例高脂血症者按血脂水平随机分为受试组和对照组,受试组连续服用虾青素胶囊45d,对照组服用相同外观的安慰剂。服用前后测定血清中总胆固醇(TC)、甘油三酯(TG)和高密度脂蛋白胆固醇(HDL-C)水平和安全性指标。结果试食后受试组TC水平明显下降,下降率为13.04%,自身前后比较及与对照组比较差异有统计学意义(P<0.01);TG水平明显下降,下降率为16.75%,自身前后比较及与对照组比较差异有统计学意义(P<0.05);HDL-C水平无明显变化。各项安全性指标试验前后均无明显改变。结论虾青素胶囊对高脂血症人群具有辅助降血脂作用。
Objective To investigate the effect of astaxanthin capsule on the hypolipidemic effect of hyperlipidemia. Methods One hundred and ten cases of hyperlipidemia were randomly divided into test group and control group according to the level of blood lipid. Astaxanthin capsules were administered continuously for 45 days in the test group and placebo in the same appearance in the control group. Serum levels of total cholesterol (TC), triglyceride (TG) and high-density lipoprotein cholesterol (HDL-C) and safety indicators were measured before and after taking it. Results The level of TC in the test group decreased significantly after the test, with the rate of decrease being 13.04%. There was a significant difference between before and after treatment (P <0.01), the level of TG was significantly decreased, the rate of decrease was 16.75% Compared with the control group, the difference was statistically significant (P <0.05); HDL-C levels did not change significantly. The safety indicators before and after the test had no significant change. Conclusion Astaxanthin capsule has the effect of reducing blood fat in hyperlipidemic patients.